Radioactive seeds may help control cancer that resists standard treatment

NCT ID NCT07333651

Not yet recruiting Disease control Sponsor: Li Min Source: ClinicalTrials.gov ↗

First seen Jan 12, 2026 · Last updated May 23, 2026 · Updated 24 times

Summary

This study is for people with lung or colorectal cancer that has spread and is starting to grow again in only a few places while other areas stay stable. It tests whether adding tiny radioactive seeds (125I) directly into those growing spots, along with continuing usual treatment, can keep the cancer from progressing longer than usual treatment alone. About 90 adults will take part in this phase 2 trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OLIGOMETASTATIC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The 960th Hospital of People's Liberation Army (PLA)

    Jinan, Shandong, 250031, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.